Market Overview:
The global soft tissue reconstruction units market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of sports injuries, rising awareness about soft tissue reconstruction procedures, and technological advancements in surgical instruments and implants. The global soft tissue reconstruction units market is segmented on the basis of type into biotic units and synthetic units. The biotic unit segment is further sub-segmented into allografts, xenografts, and autologous grafts. The synthetic unit segment is further sub-segmented into prosthetic devices and non-prosthetic devices. On the basis of application, the market is divided into hospitals, clinics, and other applications such as research institutes and training centers. Geographically, the global soft tissue reconstruction units market is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U K), Asia Pacific (Japan China India Australia South Korea) Middle East & Africa(GCC Countries Saudi Arabia South Africa).
Product Definition:
Soft tissue reconstruction units are medical devices that are used to help rebuild soft tissues in the body. These units can be used to help rebuild tissues that have been damaged by injury or disease, and can also be used to promote healing in other areas of the body. The importance of soft tissue reconstruction units lies in their ability to help improve the quality of life for patients who have suffered damage to their soft tissues.
Biotic Units:
Biotic units are a measure of the effectiveness of antibiotics in inhibiting the growth of bacteria. They are used as an antibiotic endpoint and as a bacterial concentration indicator in antimicrobial susceptibility testing.
The global increase in surgical procedures has led to an upsurge in soft tissue reconstruction procedures, which is expected to drive market growth over the forecast period.
Synthetic Units:
The synthetic units are used in soft tissue reconstruction procedures. The soft tissues can be divided into two groups, namely connective and supportive tissues. Connective tissues include collagen types I, II, III & IV; elastin; and fibroblastomainous cells.
Application Insights:
The hospital application segment accounted for the largest revenue share in 2016 and is anticipated to maintain its dominance over the forecast period. This can be attributed to a large number of soft tissue reconstructive procedures being performed at hospitals, which require these devices. Furthermore, rising cases of trauma across the globe are increasing demand for these devices in hospitals. The clinic application segment is expected to witness lucrative growth over the forecast period owing to an increase in demand for minimally invasive surgeries and availability of advanced surgical tools that help achieve better results with less pain and suffering.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in demand for soft tissue reconstruction procedures and favorable reimbursement policies. The region is expected to maintain its dominance over the forecast period due to factors such as increasing healthcare expenditure, high prevalence of chronic diseases, and growing aging population. Moreover, an increase in road accidents has led North America governments to introduce laws that address insurance coverage for various injuries sustained during car crashes. This factor is also likely to boost industry growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the next eight years owing with rapid urbanization and rising disposable income especially among middle-class income groups; which are subsequently leading towards an increase in consumer health spending patterns across this region. Furthermore, government initiatives aimed at improving healthcare infrastructure are further expected drive industry expansion within Asia Pacific during the same period (8 years).
Growth Factors:
- Increasing incidence of soft tissue injuries: The increasing incidence of soft tissue injuries is one of the key growth drivers for the global Soft Tissue Reconstruction Units market. According to a study by the Centers for Disease Control and Prevention (CDC), every year around 2 million people in the U.S. suffer from sports-related injuries, which often require surgical treatment. This is expected to drive demand for Soft Tissue Reconstruction Units in the country over the forecast period.
- Rising awareness about advanced surgical procedures: The growing awareness about advanced surgical procedures is another key factor that is expected to fuel demand for Soft Tissue Reconstruction Units globally over the forecast period. Surgeons are increasingly adopting innovative techniques such as minimally invasive surgery (MIS) and laparoscopy, which help reduce post-operative complications and improve patient outcomes. This is likely to boost demand for Soft Tissue Reconstruction Units in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Soft Tissue Reconstruction Units Market Research Report
By Type
Biotic Units, Synthetic Units
By Application
Hospital, Clinic, Other
By Companies
Oxford Medicine, Johnson & Johnson, CryoLife, Inc., Integra Lifesciences Corporation, Smith & Nephew, BD, Medtronic, Organogenesis, Stryker Corporation, Zimmer Biomet
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Soft Tissue Reconstruction Units Market Report Segments:
The global Soft Tissue Reconstruction Units market is segmented on the basis of:
Types
Biotic Units, Synthetic Units
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Oxford Medicine
- Johnson & Johnson
- CryoLife, Inc.
- Integra Lifesciences Corporation
- Smith & Nephew
- BD
- Medtronic
- Organogenesis
- Stryker Corporation
- Zimmer Biomet
Highlights of The Soft Tissue Reconstruction Units Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biotic Units
- Synthetic Units
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Soft Tissue Reconstruction Units Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A soft tissue reconstruction unit is a medical facility that specializes in the repair and reconstruction of soft tissues, such as muscles, tendons, ligaments and skin. These units are typically located in hospitals or clinics.
Some of the major players in the soft tissue reconstruction units market are Oxford Medicine, Johnson & Johnson, CryoLife, Inc., Integra Lifesciences Corporation, Smith & Nephew, BD, Medtronic, Organogenesis, Stryker Corporation, Zimmer Biomet.
The soft tissue reconstruction units market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Soft Tissue Reconstruction Units Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Soft Tissue Reconstruction Units Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Soft Tissue Reconstruction Units Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Soft Tissue Reconstruction Units Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Soft Tissue Reconstruction Units Market Size & Forecast, 2018-2028
4.5.1 Soft Tissue Reconstruction Units Market Size and Y-o-Y Growth
4.5.2 Soft Tissue Reconstruction Units Market Absolute $ Opportunity
Chapter 5 Global Soft Tissue Reconstruction Units Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Soft Tissue Reconstruction Units Market Size Forecast by Type
5.2.1 Biotic Units
5.2.2 Synthetic Units
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Soft Tissue Reconstruction Units Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Soft Tissue Reconstruction Units Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Soft Tissue Reconstruction Units Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Soft Tissue Reconstruction Units Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Soft Tissue Reconstruction Units Analysis and Forecast
9.1 Introduction
9.2 North America Soft Tissue Reconstruction Units Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Soft Tissue Reconstruction Units Market Size Forecast by Type
9.6.1 Biotic Units
9.6.2 Synthetic Units
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Soft Tissue Reconstruction Units Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Soft Tissue Reconstruction Units Analysis and Forecast
10.1 Introduction
10.2 Europe Soft Tissue Reconstruction Units Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Soft Tissue Reconstruction Units Market Size Forecast by Type
10.6.1 Biotic Units
10.6.2 Synthetic Units
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Soft Tissue Reconstruction Units Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Soft Tissue Reconstruction Units Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Soft Tissue Reconstruction Units Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Soft Tissue Reconstruction Units Market Size Forecast by Type
11.6.1 Biotic Units
11.6.2 Synthetic Units
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Soft Tissue Reconstruction Units Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Soft Tissue Reconstruction Units Analysis and Forecast
12.1 Introduction
12.2 Latin America Soft Tissue Reconstruction Units Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Soft Tissue Reconstruction Units Market Size Forecast by Type
12.6.1 Biotic Units
12.6.2 Synthetic Units
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Soft Tissue Reconstruction Units Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Soft Tissue Reconstruction Units Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Soft Tissue Reconstruction Units Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Soft Tissue Reconstruction Units Market Size Forecast by Type
13.6.1 Biotic Units
13.6.2 Synthetic Units
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Soft Tissue Reconstruction Units Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Soft Tissue Reconstruction Units Market: Competitive Dashboard
14.2 Global Soft Tissue Reconstruction Units Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Oxford Medicine
14.3.2 Johnson & Johnson
14.3.3 CryoLife, Inc.
14.3.4 Integra Lifesciences Corporation
14.3.5 Smith & Nephew
14.3.6 BD
14.3.7 Medtronic
14.3.8 Organogenesis
14.3.9 Stryker Corporation
14.3.10 Zimmer Biomet
